Mammalian Genome

, Volume 20, Issue 9–10, pp 612–623

Epigenetic mechanisms underlying extinction of memory and drug-seeking behavior

Article

Abstract

An increasing body of evidence shows that structural modifications of chromatin, the DNA–protein complex that packages genomic DNA, do not only participate in maintaining cellular memory (e.g., cell fate), but they may also underlie the strengthening and maintenance of synaptic connections required for long-term changes in behavior. Accordingly, epigenetics has become a central topic in several neurobiology fields such as memory, drug addiction, and several psychiatric and mental disorders. This interest is justified as dynamic chromatin modifications may provide not only transient but also stable (or even potentially permanent) epigenetic marks to facilitate, maintain, or block transcriptional processes, which in turn may participate in the molecular neural adaptations underlying behavioral changes. Through epigenetic mechanisms the genome may be indexed in response to environmental signals, resulting in specific neural modifications that largely determine the future behavior of an organism. In this review we discuss recent advances in our understanding of how epigenetic mechanisms contribute to the formation of long-term memory and drug-seeking behavior and potentially how to apply that knowledge to the extinction of memory and drug-seeking behavior.

References

  1. Abel T, Zukin RS (2008) Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol 8:57–64PubMedCrossRefGoogle Scholar
  2. Alarcon JM, Malleret G, Touzani K, Vronskaya S, Ishii S et al (2004) Chromatin acetylation, memory, and LTP are impaired in CBP +/− mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron 42:947–959PubMedCrossRefGoogle Scholar
  3. Alberini CM (2009) Transcription factors in long-term memory and synaptic plasticity. Physiol Rev 89:121–145PubMedCrossRefGoogle Scholar
  4. Allis CD, Jenuwein T, Reinberg D (2007) Epigenetics, illustrated ed. CSHL Press, Cold Spring HarborGoogle Scholar
  5. Anagnostaras SG, Robinson TE (1996) Sensitization to the psychomotor stimulant effects of amphetamine: modulation by associative learning. Behav Neurosci 110:1397–1414PubMedCrossRefGoogle Scholar
  6. Ausio J (2006) Histone variants—the structure behind the function. Brief Funct Genomic Proteomic 5:228–243PubMedCrossRefGoogle Scholar
  7. Barrett RM, Wood MA (2008) Beyond transcription factors: the role of chromatin modifying enzymes in regulating transcription required for memory. Learn Mem 15:460–467PubMedCrossRefGoogle Scholar
  8. Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A (2009) An operational definition of epigenetics. Genes Dev 23:781–783PubMedCrossRefGoogle Scholar
  9. Berke JD, Hyman SE (2000) Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25:515–532PubMedCrossRefGoogle Scholar
  10. Bilbao A, Parkitna JR, Engblom D, Perreau-Lenz S, Sanchis-Segura C et al (2008) Loss of the Ca2+/calmodulin-dependent protein kinase type IV in dopaminoceptive neurons enhances behavioral effects of cocaine. Proc Natl Acad Sci USA 105:17549–17554PubMedCrossRefGoogle Scholar
  11. Botreau F, Paolone G, Stewart J (2006) d-Cycloserine facilitates extinction of a cocaine-induced conditioned place preference. Behav Brain Res 172:173–178PubMedCrossRefGoogle Scholar
  12. Bourtchouladze R, Lidge R, Catapano R, Stanley J, Gossweiler S et al (2003) A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4. Proc Natl Acad Sci USA 100:10518–10522PubMedCrossRefGoogle Scholar
  13. Bouton ME (1993) Context, time, and memory retrieval in the interference paradigms of Pavlovian learning. Psychol Bull 114:80–99PubMedCrossRefGoogle Scholar
  14. Bouton ME (2004) Context and behavioral processes in extinction. Learn Mem 11:485–494PubMedCrossRefGoogle Scholar
  15. Bouton ME, Moody EW (2004) Memory processes in classical conditioning. Neurosci Biobehav Rev 28:663–674PubMedCrossRefGoogle Scholar
  16. Brami-Cherrier K, Roze E, Girault JA, Betuing S, Caboche J (2009) Role of the ERK/MSK1 signalling pathway in chromatin remodelling and brain responses to drugs of abuse. J Neurochem 108:1323–1335PubMedCrossRefGoogle Scholar
  17. Brami-Cherrier K, Valjent E, Hervé D, Darragh J, Corvol JC, Pages C, Arthur SJ, Girault JA, Caboche J (2005) Parsing molecular and behavioral effects of cocaine in mitogen- and stress-activated protein kinase-1-deficient mice. J Neurosci 25(49):11444–11454PubMedCrossRefGoogle Scholar
  18. Bredy TW, Barad M (2008) The histone deacetylase inhibitor valproic acid enhances acquisition, extinction, and reconsolidation of conditioned fear. Learn Mem 15:39–45PubMedCrossRefGoogle Scholar
  19. Bredy TW, Wu H, Crego C, Zellhoefer J, Sun YE et al (2007) Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn Mem 14:268–276PubMedCrossRefGoogle Scholar
  20. Cassel S, Carouge D, Gensburger C, Anglard P, Burgun C et al (2006) Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol Pharmacol 70:487–492PubMedCrossRefGoogle Scholar
  21. Chawla S, Vanhoutte P, Arnold FJ, Huang CL, Bading H (2003) Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5. J Neurochem 85:151–159PubMedCrossRefGoogle Scholar
  22. Chhatwal JP, Myers KM, Ressler KJ, Davis M (2005) Regulation of gephyrin and GABAA receptor binding within the amygdala after fear acquisition and extinction. J Neurosci 25:502–506PubMedCrossRefGoogle Scholar
  23. Chhatwal JP, Stanek-Rattiner L, Davis M, Ressler KJ (2006) Amygdala BDNF signaling is required for consolidation but not encoding of extinction. Nat Neurosci 9:870–872PubMedCrossRefGoogle Scholar
  24. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M et al (1999) Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156:11–18PubMedGoogle Scholar
  25. Conklin CA, Tiffany ST (2002) Applying extinction research and theory to cue-exposure addiction treatments. Addiction 97:155–167PubMedCrossRefGoogle Scholar
  26. Ehrman RN, Robbins SJ, Childress AR, O’Brien CP (1992) Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology (Berl) 107:523–529CrossRefGoogle Scholar
  27. Everitt BJ, Belin D, Economidou D, Pelloux Y, Dalley JW et al (2008) Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci 363:3125–3135PubMedCrossRefGoogle Scholar
  28. Everitt BJ, Robbins TW (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8:1481–1489PubMedCrossRefGoogle Scholar
  29. Fontan-Lozano A, Romero-Granados R, Troncoso J, Munera A, Delgado-Garcia JM et al (2008) Histone deacetylase inhibitors improve learning consolidation in young and in KA-induced-neurodegeneration and SAMP-8-mutant mice. Mol Cell Neurosci 39:193–201PubMedCrossRefGoogle Scholar
  30. Fraschini A, Bottone MG, Scovassi AI, Denegri M, Risueno MC et al (2005) Changes in extranucleolar transcription during actinomycin D-induced apoptosis. Histol Histopathol 20:107–117PubMedGoogle Scholar
  31. Freeman WM, Patel KM, Brucklacher RM, Lull ME, Erwin M et al (2008) Persistent alterations in mesolimbic gene expression with abstinence from cocaine self-administration. Neuropsychopharmacology 33:1807–1817PubMedCrossRefGoogle Scholar
  32. Garakani A, Mathew SJ, Charney DS (2006) Neurobiology of anxiety disorders and implications for treatment. Mt Sinai J Med 73:941–949PubMedGoogle Scholar
  33. Graff J, Mansuy IM (2008) Epigenetic codes in cognition and behaviour. Behav Brain Res 192:70–87PubMedCrossRefGoogle Scholar
  34. Groblewski PA, Lattal KM, Cunningham CL (2009) Effects of D-cycloserine on extinction and reconditioning of ethanol-seeking behavior in mice. Alcohol Clin Exp Res 33:772–782PubMedCrossRefGoogle Scholar
  35. Guan Z, Giustetto M, Lomvardas S, Kim JH, Miniaci MC et al (2002) Integration of long-term-memory-related synaptic plasticity involves bidirectional regulation of gene expression and chromatin structure. Cell 111:483–493PubMedCrossRefGoogle Scholar
  36. Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N et al (2009) HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459:55–60PubMedCrossRefGoogle Scholar
  37. Guastella AJ, Dadds MR, Lovibond PF, Mitchell P, Richardson R (2007) A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear. J Psychiatr Res 41:466–471PubMedCrossRefGoogle Scholar
  38. Haig D (2004) The (dual) origin of epigenetics. Cold Spring Harb Symp Quant Biol 69:67–70PubMedCrossRefGoogle Scholar
  39. Heather N, Bradley BP (1990) Cue exposure as a practical treatment for addictive disorders: why are we waiting? Addict Behav 15:335–337PubMedCrossRefGoogle Scholar
  40. Heldt SA, Ressler KJ (2007) Training-induced changes in the expression of GABAA-associated genes in the amygdala after the acquisition and extinction of Pavlovian fear. Eur J Neurosci 26:3631–3644PubMedCrossRefGoogle Scholar
  41. Herry C, Mons N (2004) Resistance to extinction is associated with impaired immediate early gene induction in medial prefrontal cortex and amygdala. Eur J Neurosci 20:781–790PubMedCrossRefGoogle Scholar
  42. Hyman SE (2005) Addiction: a disease of learning and memory. Am J Psychiatry 162:1414–1422PubMedCrossRefGoogle Scholar
  43. Hyman SE, Malenka RC, Nestler EJ (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29:565–598PubMedCrossRefGoogle Scholar
  44. Jones S, Bonci A (2005) Synaptic plasticity and drug addiction. Curr Opin Pharmacol 5:20–25PubMedCrossRefGoogle Scholar
  45. Kalda A, Heidmets LT, Shen HY, Zharkovsky A, Chen JF (2007) Histone deacetylase inhibitors modulate the induction and expression of amphetamine-induced behavioral sensitization partially through an associated learning of the environment in mice. Behav Brain Res 181:76–84PubMedCrossRefGoogle Scholar
  46. Kalivas PW, Duffy P (1993) Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 13:266–275PubMedGoogle Scholar
  47. Kalivas PW, O’Brien C (2008) Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 33:166–180PubMedCrossRefGoogle Scholar
  48. Kalivas PW, Volkow N, Seamans J (2005) Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron 45:647–650PubMedCrossRefGoogle Scholar
  49. Kelley JB, Anderson KL, Itzhak Y (2007) Long-term memory of cocaine-associated context: disruption and reinstatement. Neuroreport 18:777–780PubMedCrossRefGoogle Scholar
  50. Kilts CD, Schweitzer JB, Quinn CK, Gross RE, Faber TL et al (2001) Neural activity related to drug craving in cocaine addiction. Arch Gen Psychiatry 58:334–341PubMedCrossRefGoogle Scholar
  51. Kim JS, Shukla SD (2006) Acute in vivo effect of ethanol (binge drinking) on histone H3 modifications in rat tissues. Alcohol Alcohol 41:126–132PubMedGoogle Scholar
  52. Korzus E, Rosenfeld MG, Mayford M (2004) CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 42:961–972PubMedCrossRefGoogle Scholar
  53. Kouzarides T (2007) Chromatin modifications and their function. Cell 128:693–705PubMedCrossRefGoogle Scholar
  54. Kumar A, Choi KH, Renthal W, Tsankova NM, Theobald DE et al (2005) Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 48:303–314PubMedCrossRefGoogle Scholar
  55. Kushner MG, Kim SW, Donahue C, Thuras P, Adson D et al (2007) D-cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biol Psychiatry 62:835–838PubMedCrossRefGoogle Scholar
  56. Lattal KM, Stafford JM (2008) What does it take to demonstrate memory erasure? Theoretical comment on Norrholm et al. (2008). Behav Neurosci 122:1186–1190PubMedCrossRefGoogle Scholar
  57. Lattal KM, Radulovic J, Lukowiak K (2006) Extinction: [corrected] does it or doesn’t it? The requirement of altered gene activity and new protein synthesis. Biol Psychiatry 60:344–351PubMedCrossRefGoogle Scholar
  58. Lattal KM, Barrett RM, Wood MA (2007) Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. Behav Neurosci 121:1125–1131PubMedCrossRefGoogle Scholar
  59. Ledgerwood L, Richardson R, Cranney J (2005) D-cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction. Biol Psychiatry 57:841–847PubMedCrossRefGoogle Scholar
  60. Levenson JM, Sweatt JD (2005) Epigenetic mechanisms in memory formation. Nat Rev Neurosci 6:108–118PubMedCrossRefGoogle Scholar
  61. Levenson JM, O’Riordan KJ, Brown KD, Trinh MA, Molfese DL et al (2004) Regulation of histone acetylation during memory formation in the hippocampus. J Biol Chem 279:40545–40559PubMedCrossRefGoogle Scholar
  62. Levenson JM, Roth TL, Lubin FD, Miller CA, Huang IC et al (2006) Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J Biol Chem 281:15763–15773PubMedCrossRefGoogle Scholar
  63. Levine AA, Guan Z, Barco A, Xu S, Kandel ER et al (2005) CREB-binding protein controls response to cocaine by acetylating histones at the fosB promoter in the mouse striatum. Proc Natl Acad Sci USA 102:19186–19191PubMedCrossRefGoogle Scholar
  64. Lubin FD, Roth TL, Sweatt JD (2008) Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J Neurosci 28:10576–10586PubMedCrossRefGoogle Scholar
  65. Malvaez M, Sanchis-Segura C, Vo D, Lattal KM, Wood MA (2009) Modulation of histone modification facilitates extinction of cocaine-induced conditioned place preference. Biol Psychiatry (accepted for publication)Google Scholar
  66. Maren S, Quirk GJ (2004) Neuronal signalling of fear memory. Nat Rev Neurosci 5:844–852PubMedCrossRefGoogle Scholar
  67. Mattson BJ, Bossert JM, Simmons DE, Nozaki N, Nagarkar D et al (2005) Cocaine-induced CREB phosphorylation in nucleus accumbens of cocaine-sensitized rats is enabled by enhanced activation of extracellular signal-related kinase, but not protein kinase A. J Neurochem 95:1481–1494PubMedCrossRefGoogle Scholar
  68. McClung CA, Nestler EJ (2008) Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 33:3–17PubMedCrossRefGoogle Scholar
  69. McLellan AT, Lewis DC, O’Brien CP, Kleber HD (2000) Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 284:1689–1695PubMedCrossRefGoogle Scholar
  70. Meaney MJ, Szyf M (2005) Maternal care as a model for experience-dependent chromatin plasticity? Trends Neurosci 28:456–463PubMedCrossRefGoogle Scholar
  71. Mickley GA, Hoxha Z, Bacik S, Kenmuir CL, Wellman JA et al (2007) Spontaneous recovery of a conditioned taste aversion differentially alters extinction-induced changes in c-Fos protein expression in rat amygdala and neocortex. Brain Res 1152:139–157PubMedCrossRefGoogle Scholar
  72. Miller CA, Sweatt JD (2007) Covalent modification of DNA regulates memory formation. Neuron 53:857–869PubMedCrossRefGoogle Scholar
  73. Mueller D, Porter JT, Quirk GJ (2008) Noradrenergic signaling in infralimbic cortex increases cell excitability and strengthens memory for fear extinction. J Neurosci 28:369–375PubMedCrossRefGoogle Scholar
  74. Nestler EJ, Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278:58–63PubMedCrossRefGoogle Scholar
  75. Norberg MM, Diefenbach GJ, Tolin DF (2008a) Quality of life and anxiety and depressive disorder comorbidity. J Anxiety Disord 22:1516–1522PubMedCrossRefGoogle Scholar
  76. Norberg MM, Krystal JH, Tolin DF (2008b) A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biol Psychiatry 63:1118–1126PubMedCrossRefGoogle Scholar
  77. O’Brien CP, Childress AR, McLellan T, Ehrman R (1990) Integrating systemic cue exposure with standard treatment in recovering drug dependent patients. Addict Behav 15:355–365PubMedCrossRefGoogle Scholar
  78. O’Brien CP, Childress AR, Ehrman R, Robbins SJ (1998) Conditioning factors in drug abuse: can they explain compulsion? J Psychopharmacol 12:15–22PubMedCrossRefGoogle Scholar
  79. Oike Y, Hata A, Mamiya T, Kaname T, Noda Y et al (1999) Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. Hum Mol Genet 8:387–396PubMedCrossRefGoogle Scholar
  80. Oliveira AM, Wood MA, McDonough CB, Abel T (2007) Transgenic mice expressing an inhibitory truncated form of p300 exhibit long-term memory deficits. Learn Mem 14:564–572PubMedCrossRefGoogle Scholar
  81. Pandey SC, Ugale R, Zhang H, Tang L, Prakash A (2008) Brain chromatin remodeling: a novel mechanism of alcoholism. J Neurosci 28:3729–3737PubMedCrossRefGoogle Scholar
  82. Paolone G, Botreau F, Stewart J (2009) The facilitative effects of D-cycloserine on extinction of a cocaine-induced conditioned place preference can be long lasting and resistant to reinstatement. Psychopharmacology (Berl) 202:403–409CrossRefGoogle Scholar
  83. Pascual M, Boix J, Felipo V, Guerri C (2009) Repeated alcohol administration during adolescence causes changes in the mesolimbic dopaminergic and glutamatergic systems and promotes alcohol intake in the adult rat. J Neurochem 108:920–931PubMedCrossRefGoogle Scholar
  84. Pavlov IP (1927) Conditioned reflexes. An invesitgation of the physiological activity of the cerebral cortex. Oxford University Press, LondonGoogle Scholar
  85. Pearce JM (1987) A model for stimulus generalization in Pavlovian conditioning. Psychol Rev 94:61–73PubMedCrossRefGoogle Scholar
  86. Raw M, Russell MA (1980) Rapid smoking, cue exposure and support in the modification of smoking. Behav Res Ther 18:363–372PubMedCrossRefGoogle Scholar
  87. Renthal W, Nestler EJ (2008) Epigenetic mechanisms in drug addiction. Trends Mol Med 14:341–350PubMedCrossRefGoogle Scholar
  88. Renthal W, Maze I, Krishnan V, Covington HE III, Xiao G et al (2007) Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 56:517–529PubMedCrossRefGoogle Scholar
  89. Renthal W, Carle TL, Maze I, Covington HE III, Truong HT et al (2008) Delta FosB mediates epigenetic desensitization of the c-fos gene after chronic amphetamine exposure. J Neurosci 28:7344–7349PubMedCrossRefGoogle Scholar
  90. Ressler KJ, Mayberg HS (2007) Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci 10:1116–1124PubMedCrossRefGoogle Scholar
  91. Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K et al (2004) Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 61:1136–1144PubMedCrossRefGoogle Scholar
  92. Robbins TW, Ersche KD, Everitt BJ (2008) Drug addiction and the memory systems of the brain. Ann N Y Acad Sci 1141:1–21PubMedCrossRefGoogle Scholar
  93. Robinson TE, Berridge KC (2000) The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95(Suppl 2):S91–S117PubMedGoogle Scholar
  94. Robinson TE, Berridge KC (2003) Addiction. Annu Rev Psychol 54:25–53PubMedCrossRefGoogle Scholar
  95. Romieu P, Host L, Gobaille S, Sandner G, Aunis D et al (2008) Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration in rats. J Neurosci 28:9342–9348PubMedCrossRefGoogle Scholar
  96. Rothbaum BO, Davis M (2003) Applying learning principles to the treatment of post-trauma reactions. Ann N Y Acad Sci 1008:112–121PubMedCrossRefGoogle Scholar
  97. Saha A, Wittmeyer J, Cairns BR (2006a) Chromatin remodelling: the industrial revolution of DNA around histones. Nat Rev Mol Cell Biol 7:437–447PubMedCrossRefGoogle Scholar
  98. Saha A, Wittmeyer J, Cairns BR (2006b) Mechanisms for nucleosome movement by ATP-dependent chromatin remodeling complexes. Results Probl Cell Differ 41:127–148PubMedCrossRefGoogle Scholar
  99. Sanchis-Segura C, Lopez-Atalaya JP, Barco A (2009) Selective boosting of transcriptional and behavioral responses to drugs of abuse by histone deacetylase inhibition. Neuropsychopharmacology. doi:10.1038/npp.2009.125
  100. Schroeder FA, Penta KL, Matevossian A, Jones SR, Konradi C et al (2008) Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors. Neuropsychopharmacology 33:2981–2992PubMedCrossRefGoogle Scholar
  101. Shearer SL (2007) Recent advances in the understanding and treatment of anxiety disorders. Prim Care 34:475–504, v–viGoogle Scholar
  102. Shen HY, Kalda A, Yu L, Ferrara J, Zhu J et al (2008) Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice. Neuroscience 157:644–655PubMedCrossRefGoogle Scholar
  103. Shim D, Kang HY, Jeon BW, Kang SS, Chang SI et al (2004) Protein kinase B inhibits apoptosis induced by actinomycin D in ECV304 cells through phosphorylation of caspase 8. Arch Biochem Biophys 425:214–220PubMedCrossRefGoogle Scholar
  104. Stefanko DP, Barrett RM, Ly AR, Reolon GK, Wood MA (2009) Modulation of long-term memory for object recognition via HDAC inhibition. Proc Natl Acad Sci USA 106:9447–9452PubMedCrossRefGoogle Scholar
  105. Storch EA, Merlo LJ, Bengtson M, Murphy TK, Lewis MH et al (2007) D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Int Clin Psychopharmacol 22:230–237PubMedCrossRefGoogle Scholar
  106. Sun J, Wang L, Jiang B, Hui B, Lv Z et al (2008) The effects of sodium butyrate, an inhibitor of histone deacetylase, on the cocaine- and sucrose-maintained self-administration in rats. Neurosci Lett 441:72–76PubMedCrossRefGoogle Scholar
  107. Szyf M (2009) Epigenetics, DNA methylation, and chromatin modifying drugs. Annu Rev Pharmacol Toxicol 49:243–263PubMedCrossRefGoogle Scholar
  108. Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ (2007) How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat Struct Mol Biol 14:1025–1040PubMedCrossRefGoogle Scholar
  109. Taylor JR, Olausson P, Quinn JJ, Torregrossa MM (2009) Targeting extinction and reconsolidation mechanisms to combat the impact of drug cues on addiction. Neuropharmacology 56(Suppl 1):186–195PubMedCrossRefGoogle Scholar
  110. Thanos PK, Bermeo C, Wang GJ, Volkow ND (2009) D-cycloserine accelerates the extinction of cocaine-induced conditioned place preference in C57bL/c mice. Behav Brain Res 199:345–349PubMedCrossRefGoogle Scholar
  111. Vaissiere T, Sawan C, Herceg Z (2008) Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res 659:40–48PubMedCrossRefGoogle Scholar
  112. Vecsey CG, Hawk JD, Lattal KM, Stein JM, Fabian SA et al (2007) Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J Neurosci 27:6128–6140PubMedCrossRefGoogle Scholar
  113. Vengeliene V, Kiefer F, Spanagel R (2008) D-cycloserine facilitates extinction of conditioned alcohol-seeking behaviour in rats. Alcohol Alcohol 43:626–629PubMedGoogle Scholar
  114. Vianna MR, Igaz LM, Coitinho AS, Medina JH, Izquierdo I (2003) Memory extinction requires gene expression in rat hippocampus. Neurobiol Learn Mem 79:199–203PubMedCrossRefGoogle Scholar
  115. Waddington CH (1942) The epigenotype. Endeavor 1:18–20Google Scholar
  116. Walker DL, Ressler KJ, Lu KT, Davis M (2002) Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci 22:2343–2351PubMedGoogle Scholar
  117. Weaver IC, Cervoni N, Champagne FA, D’Alessio AC, Sharma S et al (2004) Epigenetic programming by maternal behavior. Nat Neurosci 7:847–854PubMedCrossRefGoogle Scholar
  118. Wood MA, Kaplan MP, Park A, Blanchard EJ, Oliveira AM et al (2005) Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage. Learn Mem 12:111–119PubMedCrossRefGoogle Scholar
  119. Wood MA, Attner MA, Oliveira AM, Brindle PK, Abel T (2006) A transcription factor-binding domain of the coactivator CBP is essential for long-term memory and the expression of specific target genes. Learn Mem 13:609–617PubMedCrossRefGoogle Scholar
  120. Woods AM, Bouton ME (2006) D-cycloserine facilitates extinction but does not eliminate renewal of the conditioned emotional response. Behav Neurosci 120:1159–1162PubMedCrossRefGoogle Scholar
  121. Yang YL, Lu KT (2005) Facilitation of conditioned fear extinction by d-cycloserine is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase cascades and requires de novo protein synthesis in basolateral nucleus of amygdala. Neuroscience 134:247–260PubMedCrossRefGoogle Scholar
  122. Yeh SH, Lin CH, Gean PW (2004) Acetylation of nuclear factor-kappaB in rat amygdala improves long-term but not short-term retention of fear memory. Mol Pharmacol 65:1286–1292PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Department of Neurobiology and Behavior, Center for the Neurobiology of Learning and MemoryUniversity of California, IrvineIrvineUSA
  2. 2.Area de PsicobiologiaUniversitat Jaume ICastellonSpain

Personalised recommendations